Clinical Trial Update: Natural Killer (NK) Cell Therapy in Locally Advanced HCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating natural killer (NK) cell therapy for locally advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• NK cell therapy

Snippet

Sponsor: Vaxcell Bio, Co., Ltd. | Conditions: Locally Advanced Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED